TrialLipids in health and disease2025
Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial.
Xianyou Ji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.